Intratumoral Heterogeneity of Vimentin Modulates Nuclear Mechanotransduction, DNA Damage Response and Cancer Cell Survival
Vimentin, a major intermediate filament protein, is essential for maintaining cellular integrity and regulating cytoskeletal dynamics. Its upregulation is a hallmark of epithelial-to-mesenchymal transition (EMT), a process that enhances cancer cell migration, invasion, and metastatic potential. However, single-cell transcriptomic analyses of glioblastoma, the most common and aggressive primary brain tumor, reveal that vimentin expression exhibits significant intratumoral heterogeneity, reflecting diverse cellular subpopulations that may contribute to tumor plasticity, therapy resistance, and disease progression. Here, we show that the absence of vimentin alters nuclear mechanotransduction in response to compression, leading to chromatin remodelling and profound changes in gene expression in cancer cells. Remarkably, we demonstrate that external compressive forces, akin to vimentin deficiency, disrupt DNA damage response pathways. This impairment compromises DNA damage sensing and repair, bypassing DNA damage checkpoints and apoptosis. Consequently, vimentin-negative tumor cells exhibit increased survival in response to physical stress and DNA damage, potentially driving radioresistance and further amplifying intratumoral heterogeneity.